Welcome to our dedicated page for Rocket Lab Usa SEC filings (Ticker: RKLB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Rocket Lab Corporation (Nasdaq: RKLB) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a U.S. public company. These documents include current reports on Form 8-K, proxy statements, and other filings that describe material events, governance matters, capital markets activity, and acquisitions.
Rocket Lab’s Form 8-K filings cover topics such as quarterly financial results, executive and director changes, equity offering arrangements, and significant transactions. Examples include reports of results of operations for specific quarters, the adoption of a senior executive cash incentive bonus plan, the establishment of an at-the-market equity offering program under a shelf registration statement, and the completion or announcement of acquisitions such as the purchase of the parent holding company of GEOST LLC and an agreement to acquire all shares of Mynaric AG.
The company’s proxy statement on Form DEF 14A provides detail on board structure, director elections, executive compensation, equity plans, and stockholder voting matters. It also describes the holding company reorganization that made Rocket Lab Corporation the parent of Rocket Lab USA, Inc., and outlines proposals presented to stockholders at the annual meeting.
Through these filings, investors can review information about capital raising (including at-the-market offerings), governance and compensation policies, acquisition terms, and other material corporate events. Real-time updates from EDGAR allow users to see new 8-Ks and related exhibits as they are filed.
Stock Titan’s platform associates these filings with AI-powered summaries that explain the key points of lengthy documents, helping users quickly identify items such as new financing arrangements, changes in leadership, or the structure of significant transactions. Users can also track how Rocket Lab uses registration statements and resale prospectus supplements in connection with share issuances tied to acquisitions.
Rocket Lab Corp (RKLB) filing a Form 144 notifies a proposed sale of 874,588 common shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of $41,985,296.61. The filing states the shares were acquired on 09/18/2025 via previously exercised options and paid for in cash on the same date. The filer reports 479,355,713 shares outstanding for the issuer and lists an approximate sale date of 09/19/2025 on the NASDAQ. The filing indicates no securities sold by the account in the past three months and includes the standard representation that the seller is not aware of undisclosed material adverse information.
Rocket Lab Corp (RKLB) filing a Form 144 notifies a proposed sale of 874,588 common shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of $41,985,296.61. The filing states the shares were acquired on 09/18/2025 via previously exercised options and paid for in cash on the same date. The filer reports 479,355,713 shares outstanding for the issuer and lists an approximate sale date of 09/19/2025 on the NASDAQ. The filing indicates no securities sold by the account in the past three months and includes the standard representation that the seller is not aware of undisclosed material adverse information.
Matthew Ocko, a director of Rocket Lab Corp (RKLB), reported multiple dispositions of Common Stock on 09/16/2025. The Form 4 shows a series of sales and distributions that in aggregate disposed of 3,920,112 shares on that date at weighted average prices reported in grouped ranges from about $47.01 to $52.45 per share. The table lists multiple sale tranches (individual weighted-average prices shown in footnotes) and additional distributions for no consideration to limited partners and related entities, with certain shares held indirectly through venture funds and management entities. The filing includes footnotes clarifying record holders, distributions to partners, and disclaimers of beneficial ownership except to the extent of any pecuniary interest.
Matthew Ocko, a director of Rocket Lab Corp (RKLB), reported multiple dispositions of Common Stock on 09/16/2025. The Form 4 shows a series of sales and distributions that in aggregate disposed of 3,920,112 shares on that date at weighted average prices reported in grouped ranges from about $47.01 to $52.45 per share. The table lists multiple sale tranches (individual weighted-average prices shown in footnotes) and additional distributions for no consideration to limited partners and related entities, with certain shares held indirectly through venture funds and management entities. The filing includes footnotes clarifying record holders, distributions to partners, and disclaimers of beneficial ownership except to the extent of any pecuniary interest.
Adam C. Spice, Chief Financial Officer of Rocket Lab Corp (RKLB), reported multiple sales of common stock on 09/16/2025 as shown on Form 4. The transactions are described as "sell-to-cover" sales to satisfy tax withholding on the vesting and settlement of previously granted restricted stock units. The reported disposals were: 12,358 shares at a weighted-average price of $47.785, 31,843 shares at $48.6044, 13,743 shares at $49.4143, 6,686 shares at $50.5206 and 3,624 shares at $51.6341. Following these transactions, the reporting person’s direct beneficial ownership decreased to 1,064,981 shares. The Form 4 was signed on behalf of Mr. Spice by his attorney-in-fact on 09/18/2025.
Adam C. Spice, Chief Financial Officer of Rocket Lab Corp (RKLB), reported multiple sales of common stock on 09/16/2025 as shown on Form 4. The transactions are described as "sell-to-cover" sales to satisfy tax withholding on the vesting and settlement of previously granted restricted stock units. The reported disposals were: 12,358 shares at a weighted-average price of $47.785, 31,843 shares at $48.6044, 13,743 shares at $49.4143, 6,686 shares at $50.5206 and 3,624 shares at $51.6341. Following these transactions, the reporting person’s direct beneficial ownership decreased to 1,064,981 shares. The Form 4 was signed on behalf of Mr. Spice by his attorney-in-fact on 09/18/2025.
Frank Klein, Chief Operations Officer of Rocket Lab Corp (RKLB), reported multiple sales of common stock on September 16-17, 2025. The filings show a series of sell-to-cover transactions tied to RSU vesting and additional sales executed under a Rule 10b5-1 trading plan. Across the listed transactions the reporting person disposed of 49,821 shares at weighted-average prices that ranged roughly from $47.13 to $52.05. Following the reported dispositions, the filing shows the reporting person beneficially owned 1,316,005 shares of common stock. The form states the sales were to satisfy tax-withholding obligations and pursuant to an existing trading plan, and provides weighted-average price ranges for each tranche.
Frank Klein, Chief Operations Officer of Rocket Lab Corp (RKLB), reported multiple sales of common stock on September 16-17, 2025. The filings show a series of sell-to-cover transactions tied to RSU vesting and additional sales executed under a Rule 10b5-1 trading plan. Across the listed transactions the reporting person disposed of 49,821 shares at weighted-average prices that ranged roughly from $47.13 to $52.05. Following the reported dispositions, the filing shows the reporting person beneficially owned 1,316,005 shares of common stock. The form states the sales were to satisfy tax-withholding obligations and pursuant to an existing trading plan, and provides weighted-average price ranges for each tranche.
Rocket Lab Corp (RKLB) reporting person Arjun Kampani, SVP General Counsel, disclosed multiple sales of common stock on September 16-17, 2025. The Form 4 shows a series of dispositions totaling 40,601 shares sold, executed as both "sell-to-cover" transactions to satisfy tax withholding on vested restricted stock units and automated sales under a Rule 10b5-1 trading plan adopted December 12, 2024. Reported weighted-average prices for the sales ranged roughly from $46.53 to $52.05, with specific weighted-average prices between $47.18 and $51.63 shown for the reported lots. After these transactions, the filing shows the reporting person beneficially owned 489,629 shares.
Rocket Lab Corp (RKLB) reporting person Arjun Kampani, SVP General Counsel, disclosed multiple sales of common stock on September 16-17, 2025. The Form 4 shows a series of dispositions totaling 40,601 shares sold, executed as both "sell-to-cover" transactions to satisfy tax withholding on vested restricted stock units and automated sales under a Rule 10b5-1 trading plan adopted December 12, 2024. Reported weighted-average prices for the sales ranged roughly from $46.53 to $52.05, with specific weighted-average prices between $47.18 and $51.63 shown for the reported lots. After these transactions, the filing shows the reporting person beneficially owned 489,629 shares.
Peter Beck, Kerryn Beck, Warren Butler, Equatorial Trust and Peek Street Equatorial Trustee Limited reported a series of sales of Rocket Lab Corp (RKLB) common stock on September 15 and 16, 2025. The filings show multiple disposals executed under a Rule 10b5-1 trading plan adopted by the Equatorial Trust on June 13, 2025, with weighted average prices disclosed for groups of sales ranging from about $47.41 to $55.16 per share.
The Form 4s disclose that the shares are held directly by the Trust and that Peek Street Equatorial Trustee Limited is the trustee, with Peter Beck, Kerryn Beck and Warren Butler serving as directors of the Trustee and sharing voting and investment control; each is therefore deemed an indirect beneficial owner. Following the reported transactions, the Trust’s reported indirect beneficial ownership is shown as 2,500,000 shares in the most recent line item.
Peter Beck, Kerryn Beck, Warren Butler, Equatorial Trust and Peek Street Equatorial Trustee Limited reported a series of sales of Rocket Lab Corp (RKLB) common stock on September 15 and 16, 2025. The filings show multiple disposals executed under a Rule 10b5-1 trading plan adopted by the Equatorial Trust on June 13, 2025, with weighted average prices disclosed for groups of sales ranging from about $47.41 to $55.16 per share.
The Form 4s disclose that the shares are held directly by the Trust and that Peek Street Equatorial Trustee Limited is the trustee, with Peter Beck, Kerryn Beck and Warren Butler serving as directors of the Trustee and sharing voting and investment control; each is therefore deemed an indirect beneficial owner. Following the reported transactions, the Trust’s reported indirect beneficial ownership is shown as 2,500,000 shares in the most recent line item.
Rocket Lab Corp (RKLB) submitted a Form 144 notice reporting a proposed sale of 4,286 shares of common stock through Morgan Stanley Smith Barney LLC on the NASDAQ, with an approximate sale date of 09/17/2025. The filer reports the 4,286 shares were acquired as Restricted Stock Units from the issuer on 08/22/2025 and the aggregate market value of the proposed sale is listed as $202,492.07. The filing shows 479,355,713 shares outstanding for the issuer. The notice states there were no other sales by the reporting person in the prior three months and includes the standard representation that the seller is not aware of undisclosed material adverse information.
Rocket Lab Corp (RKLB) submitted a Form 144 notice reporting a proposed sale of 4,286 shares of common stock through Morgan Stanley Smith Barney LLC on the NASDAQ, with an approximate sale date of 09/17/2025. The filer reports the 4,286 shares were acquired as Restricted Stock Units from the issuer on 08/22/2025 and the aggregate market value of the proposed sale is listed as $202,492.07. The filing shows 479,355,713 shares outstanding for the issuer. The notice states there were no other sales by the reporting person in the prior three months and includes the standard representation that the seller is not aware of undisclosed material adverse information.
Form 144 notice for Rocket Lab Corp (RKLB): The filing indicates a proposed sale of 9,416 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $444,858.92. The shares are scheduled for sale on 09/17/2025 on NASDAQ. The securities were acquired on 08/22/2025 as Restricted Stock Units from the issuer, with payment recorded on 08/22/2025. The filing reports 479,355,713 shares outstanding and states there were no securities sold in the past three months by the account. Several standard form sections (filer identification and issuer address/contact fields) appear blank in the provided content.
Form 144 notice for Rocket Lab Corp (RKLB): The filing indicates a proposed sale of 9,416 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $444,858.92. The shares are scheduled for sale on 09/17/2025 on NASDAQ. The securities were acquired on 08/22/2025 as Restricted Stock Units from the issuer, with payment recorded on 08/22/2025. The filing reports 479,355,713 shares outstanding and states there were no securities sold in the past three months by the account. Several standard form sections (filer identification and issuer address/contact fields) appear blank in the provided content.
Rocket Lab Corp (RKLB) filed a Form 144 reporting a proposed sale of 68,254 common shares with an aggregate market value of $3,342,091.24. The notice lists the approximate sale date as 09/16/2025 on NASDAQ. The shares to be sold were acquired through restricted stock vesting on 09/15/2025, with a total of 114,845 shares acquired and payment noted as compensation. The filing states there were no securities sold by the person in the past three months. The notice includes the signers representation that they are not aware of any undisclosed material adverse information about the issuer.
Rocket Lab Corp (RKLB) filed a Form 144 reporting a proposed sale of 45,535 common shares through Morgan Stanley Smith Barney on 09/16/2025 on the NASDAQ, with an aggregate market value of $2,229,648.60. The securities were acquired on 09/15/2025 via restricted stock vesting from the issuer and were paid as compensation. The filer reports no other sales in the past three months and affirms they have no undisclosed material adverse information about the issuer.